American Express (AXP) has been back in focus after first quarter results topped expectations on both revenue and earnings, supported by resilient cardmember spending, refreshed premium products and reaffirmed full year growth targets.

Despite a 6.5% 30 day share price return and a 1.78% 7 day share price gain, American Express shares are down 14.23% year to date, even as the 1 year total shareholder return sits at 16.68% and the 3 year total shareholder return exceeds a 100% gain. Recent Q1 results and refreshed card benefits may be shifting how investors weigh growth potential against risk at around US$319.68 per share.

If strong card spending has you rethinking where growth could come from next, this is a good moment to look at 17 top founder-led companies

With Q1 earnings ahead of expectations, reaffirmed 2026 guidance, and the stock trading at an estimated 19% discount to some intrinsic value models and about 13% below the average analyst target, is this a mispricing or is future growth already reflected?

Most Popular Narrative: 3.7% Overvalued

According to the widely followed narrative by WallStreetWontons, the fair value for American Express sits at $308.19 versus the recent close around $319.68. This frames the stock as slightly above that narrative estimate while still supported by a long growth runway story.

In summary, American Express is seeing positive impacts on sales and earnings from ongoing product refreshes, strategic acquisitions, and enhancements to their Membership Model. The company is also benefiting from strong financial performance and consistent revenue growth, although it faces some challenges in its international operations.

Want to see what kind of revenue build, margin profile, and earnings path sit behind this valuation call? The narrative leans heavily on fee income strength, refreshed cards and a Membership Model that keeps high spending customers engaged over multiple years. The full write up spells out exactly how those moving parts feed into the fair value line.

Result: Fair Value of $308.19 (OVERVALUED)

However, this story can change quickly if card fee growth slows or international setbacks, such as further regulatory action, begin to pressure American Express’s earnings power.

Another Take: DCF Points the Other Way

While WallStreetWontons’ fair value of $308.19 suggests American Express is 3.7% overvalued, our DCF model points in the opposite direction. With the shares at $319.68 and a future cash flow value estimate of $393.72, the stock screens as trading at an 18.8% discount instead. Which story do you think fits better with the risks you see?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out American Express for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 50 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Curious whether the mixed signals in this article point to opportunity or risk for you personally? Act while the details are fresh in mind, weigh both sides of the story, and see how the balance of 3 key rewards and 1 important warning sign

Ready to hunt for your next idea?

If this American Express story has you thinking bigger, do not stop here. Scan other opportunities now so you are not looking back wishing you had.

• Target quality at a discount by reviewing 50 high quality undervalued stocks that combine solid fundamentals with prices that may sit below many investors’ radar.
• Focus on staying power with solid balance sheet and fundamentals stocks screener (44 results) if you want companies that prioritize financial strength and flexibility through different market conditions.
• Get ahead of the crowd by checking the screener containing 25 high quality undiscovered gems before others start paying attention and potential re ratings occur.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.